CIK 0001267602
ALIM ALIMERA SCIENCES INC
Insider trading from SEC Form 4. Last filing Mar 13, 2024.
In brief
ALIMERA SCIENCES INC (ALIM) has 12 SEC Form 4 filings on file from 8 insiders, the latest filed on Mar 13, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at ALIMERA SCIENCES INC, scored.
Transactions
Every row filed, 15 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Elliot Maltz Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +75,000 | $0.00 | $0 | 75,000 | Mar 13, 2024 |
| Mar 11, 2024 | Philip Ashman President of Int'l Operations | AGrant or award Restricted Stock Unitsderivative | +6,800 | $0.00 | $0 | 6,800 | Mar 13, 2024 |
| Mar 11, 2024 | Richard S Eiswirth Jr President and CEO | AGrant or award Restricted Stock Unitsderivative | +14,700 | $0.00 | $0 | 14,700 | Mar 13, 2024 |
| Mar 11, 2024 | Todd Michael Wood President of U.S. Operations | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Mar 13, 2024 |
| Mar 11, 2024 | Jason M. Werner Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +1,800 | $0.00 | $0 | 1,800 | Mar 13, 2024 |
| Mar 11, 2024 | Elliot Maltz Chief Financial Officer | AGrant or award Performance-Based Restricted Stock Unitsderivative | +75,000 | $0.00 | $0 | 75,000 | Mar 13, 2024 |
| Mar 11, 2024 | Philip Ashman President of Int'l Operations | AGrant or award Performance-Based Restricted Stock Unitsderivative | +75,000 | $0.00 | $0 | 75,000 | Mar 13, 2024 |
| Mar 11, 2024 | Todd Michael Wood President of U.S. Operations | AGrant or award Performance-Based Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | Mar 13, 2024 |
| Jan 10, 2024 | Philip Ashman President of Int'l Operations | FTax withholding Common Stock10b5-1 | -2,938 | $3.86 | $11k | 130,377 | Jan 11, 2024 |
| Jan 2, 2024 | Elliot Maltz Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 4, 2024 |
| Dec 11, 2023 | Todd Michael Wood President of U.S. Operations | AGrant or award Employee Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 13, 2023 |
| Nov 21, 2023 | Philip Ashman Chief Operating Officer & SVP | AGrant or award Employee Stock Option (Right to Buy)derivative | +147,000 | $0.00 | $0 | 147,000 | Nov 28, 2023 |
| Nov 21, 2023 | David Holland Chief Marketing Officer & SVP | AGrant or award Employee Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Nov 28, 2023 |
| Nov 21, 2023 | Russell Skibsted Chief Financial Officer & SVP | AGrant or award Employee Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 28, 2023 |
| Nov 7, 2023 | Margaret Pax director | AGrant or award Stock Option (Right to Buy)derivative | +36,713 | $0.00 | $0 | 36,713 | Nov 8, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Philip AshmanPresident of Int'l Operations
- Richard S Eiswirth JrPresident and CEO
- David HollandChief Marketing Officer & SVP
- Elliot MaltzChief Financial Officer
- Margaret Paxdirector
- Russell SkibstedChief Financial Officer & SVP
- Jason M. WernerChief Operating Officer
- Todd Michael WoodPresident of U.S. Operations
Questions about ALIM
Answered from the filings on this page, as of the latest one.
Are insiders buying ALIM?
No. In the last 90 days no insider at ALIMERA SCIENCES INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ALIM on the open market?
No open-market trade has been scored at ALIMERA SCIENCES INC. The latest Form 4 on file was filed on Mar 13, 2024 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at ALIMERA SCIENCES INC?
8 people have filed a Form 4 at ALIMERA SCIENCES INC, among them Philip Ashman (President of Int'l Operations), Richard S Eiswirth Jr (President and CEO), David Holland (Chief Marketing Officer & SVP). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.